GlobalData forecasts China neurosurgical robotics market to grow at 10% CAGR through 2036

The neurosurgical robotics market in China is experiencing robust growth, driven by the increasing incidence of neurological disorders, an expanding elderly population, and the escalating necessity for precision-oriented, minimally invasive procedures that enhance clinical results and reduce recovery times. Owing to these factors, the neurosurgery robotic surgical systems market will expand at a compound annual growth rate (CAGR) of 10 per cent through 2036, forecasts GlobalData.

GlobalData’s latest report, “Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that China accounted for nearly 30 per cent of the robotic surgical systems market in the Asia-Pacific region in 2024. This significant contribution is due to the country’s extensive patient population, swift advancement in healthcare modernisation, and robust government backing for the adoption of advanced medical technologies.

Brain Navi Biotechnology, a neurosurgical robotics innovator from Taiwan, has recently partnered with BenQ Medical Technology to launch and commercialise NaoTrac, an AI-driven Stereotactic Surgical Navigation Robot, in China. This collaboration is expected to advance global expansion through local partnerships, aligning with China’s 14th Five-Year Plan to accelerate adoption and deployment of advanced neurosurgical robotics worldwide.

Shagufta Hasan, Medical Devices Analyst at GlobalData, comments, “The partnership highlights the value of local alliances in accelerating the adoption of advanced neurosurgical robotics, offering benefits such as faster market entry, improved surgical precision, and enhanced patient outcomes.”

In addition, Shanghai-based Ronovo Surgical gained The National Medical Products Administration (NMPA) regulatory approval for its Carina platform—a proprietary modular system offering configurable robotic assistance for laparoscopic procedures, in March 2025. Such approvals highlight the increasing availability of robotic-assisted technologies, providing hospitals with diverse options to improve surgical outcomes.

Hasan concludes, “As China continues to prioritise intelligent healthcare solutions, strategic collaborations are set to play a pivotal role in transforming neurosurgical practices. By combining cutting-edge technology with localised expertise and infrastructure, the market is well-positioned for sustained growth, improved patient outcomes, and a stronger presence of neurosurgical robotics across Asia and beyond through 2036.”